Eligi
Med
Base de datos
Seguridad
Sobre EligiMed
Contacto
Contáctenos
Ensayos Clínicos de Enfermedades Infecciosas | EligiMed
Ensayos clínicos
887 ensayos encontrados
Completado
RENIS
AI452-021 en pacientes con hepatitis C crónica genotipo 1b que no han recibido trat. previo o sufrieron una recaída previa con la terapia con peginterferón alfa/RBV
INTERVENTIONAL
ID: IS000087
Reclutando
RENIS
Estudio de prevalencia de HPV y lesiones anogenitales en pacientes HIV positivos mujeres y hombres que tienen sexo con hombres.
OBSERVATIONAL
ID: IS000029
Terminado
Fase 3
ClinicalTrials.gov
A Phase III, Randomized, Double-blind, Placebo-controlled Multi-country Study to Demonstrate Efficacy of a Single Dose of Unadjuvanted RSV Maternal Vaccine, Administered IM to Pregnant Women 18 to 49 Years of Age, for Prevention of RSV Associated LRTIs in Their Infants up to 6 Months of Age
INTERVENTIONAL
Inicio: 20 de nov de 2020
ID: NCT04605159
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Randomised, Double Blind, Multicentre, Parallel Group, Non Inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Dolutegravir Plus Lamivudine Compared to Dolutegravir Plus Tenofovir/Emtricitabine in Human Immunodeficiency Virus 1 Infected Treatment naïve Adults
INTERVENTIONAL
Inicio: 21 de jul de 2016
ID: NCT02831673
Terminado
Fase 3
ClinicalTrials.gov
Phase III, Randomized, Observer-blind, Placebo-controlled, Multi-center, Multinational Study to Evaluate the Efficacy, Immunogenicity, and Safety of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers (PEARL)
INTERVENTIONAL
Inicio: 6 de feb de 2024
ID: NCT06252285
Completado
Fase 2
ClinicalTrials.gov
An Open-label Clinical Trial Phase IIB to Evaluate the Immunogenicity and Safety of Recombinant Novel Coronavirus Vaccine in Participants Aged 18 Years and Above That Previously Received One Dose of Sputnik V
INTERVENTIONAL
Inicio: 1 de oct de 2021
ID: NCT05293223
Completado
Fase 2
ClinicalTrials.gov
A Phase 2a Multicentre, Randomized, Open-Label, Two-Part Adaptive Design Study to Evaluate the Antiviral Effect, Safety and Tolerability of GSK3810109A, an HIV-1 Specific Broadly Neutralizing Human Monoclonal Antibody in Antiretroviral-naïve HIV-1-Infected Adults
INTERVENTIONAL
Inicio: 22 de jun de 2021
ID: NCT04871113
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2b Randomized, Active-Controlled, Double-Blind Trial to Investigate Safety, Efficacy, and Dose-response of BMS-955176, Given on a Backbone of Tenofovir/Emtricitabine, in Treatment-Naive HIV-1 Infected Adults
INTERVENTIONAL
Inicio: 12 de may de 2015
ID: NCT02415595
Terminado
Fase 3
ClinicalTrials.gov
A Double-blind, Randomized, Placebo-controlled, Parallel Group Study of Rimonabant 20 mg Daily for the Treatment of Non-diabetic Patients With Nonalcoholic Steatohepatitis (NASH)
INTERVENTIONAL
Inicio: 1 de ene de 2008
ID: NCT00576667
Completado
Fase 2
ClinicalTrials.gov
A Phase 2 Partially Observer-Blind Randomized Controlled Multicenter Dose-Ranging and Formulation-Finding Study of a New Novartis Meningococcal B Recombinant Vaccine Evaluating the Safety and Immunogenicity When Given Concomitantly With Routine Vaccines in 2-month-old Infants
INTERVENTIONAL
Inicio: 1 de jul de 2009
ID: NCT00937521
Completado
Fase 4
ClinicalTrials.gov
A Phase IV, Randomised, Multicentre, Efficacy and Safety Study Examining the Effect of Induction Dosing With the Combination of Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Infected With Hepatitis C Genotype 1
INTERVENTIONAL
Inicio: 1 de ago de 2004
ID: NCT00192647
Desconocido
Fase 2
ClinicalTrials.gov
An Open-label, Multicenter Study in Male Pediatric Patients With Cerebral X-linked Adrenoleukodystrophy (Cald) to Assess the Effects of MIN-102 Treatment on Disease Progression Prior to Human Stem Cell Transplant (HSCT)
INTERVENTIONAL
Inicio: 13 de sept de 2019
ID: NCT04528706
Terminado
Fase 3
ClinicalTrials.gov
An Open-label, Randomised Study Comparing the Uptake of rIL-2 in HIV-1 Infected Individuals Receiving Different Combinations of Antiemetics and Analgesic Agents During rIL-2 Dosing in ESPRIT: Toxicity Substudy of ESPRIT: TOXIL-2 Substudy
INTERVENTIONAL
Inicio: 1 de nov de 2005
ID: NCT00147355
Desconocido
ClinicalTrials.gov
WHF COVID-19 and Cardiovascular Disease Survey
OBSERVATIONAL
Inicio: 1 de sept de 2020
ID: NCT04475471
Completado
Fase 2
ClinicalTrials.gov
A Randomized Double-Blind Phase 2 Study Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications
INTERVENTIONAL
Inicio: 1 de sept de 2010
ID: NCT01227967
Desconocido
Fase 4
ClinicalTrials.gov
Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Prophylaxis of COVID-19 Disease in Health Personnel Dedicated to Patients Care With COVID-19. Multicenter, Randomized, Double-blind, Placebo-controlled Trial (CARR-COV-02)
INTERVENTIONAL
Inicio: 24 de jul de 2020
ID: NCT04521322
Completado
ClinicalTrials.gov
Argentinian Registry of Patients With Rheumatic Diseases and COVID-19 Infection
OBSERVATIONAL
Inicio: 18 de ago de 2020
ID: NCT04568421
Completado
Fase 2
ClinicalTrials.gov
A Pilot Phase 2a, Randomized, Double-blind, Placebo-controlled Study to Explore the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of JNJ-53718678 at Two Dose Levels in Non-Hospitalized Adult Subjects Infected With Respiratory Syncytial Virus
INTERVENTIONAL
Inicio: 6 de feb de 2018
ID: NCT03379675
Completado
Fase 3
ClinicalTrials.gov
Double-blind, Randomised, Placebo-controlled, Phase III Study Comparing the Efficacy and Safety of Bilastine 20 mg Once Daily and Levocetirizine 5 mg for the Treatment of Chronic Idiopathic Urticaria
INTERVENTIONAL
Inicio: 1 de jul de 2006
ID: NCT00421109
Completado
Fase 1
ClinicalTrials.gov
Multiple-dose, Open-label, Randomized, Safety and Pharmacokinetic Study of Tipranavir in Combination With Low-dose Ritonavir in HIV-infected Pediatric Patients
INTERVENTIONAL
Inicio: 1 de nov de 2003
ID: NCT00076999
Anterior
1
...
22
23
24
...
45
Siguiente
Filtros